comparemela.com

Page 3 - Mylan News Today : Breaking News, Live Updates & Top Stories | Vimarsana

U S Supreme Court rejects new Intel challenge to federal patent policy

The U.S. Supreme Court has also rejected previous requests by Intel, Apple and Viatris-owned generic drugmaker Mylan to review the patent office’s policy

United statesElizabeth prelogarEdwards lifesciencesUs supreme court onUs courtSupreme courtTrademark officeLog increate freePatent trialAppeal boardFederal circuitGeneral elizabeth prelogarUs patent and trademark office

Big Ten Signing Day: Ohio State class ranked best in conference Penn State, Michigan next in line

Ohio State hasn't played in the Big Ten championship game in three years, but it remains the conference's top program in recruiting.The Buckeyes were on track W

Kansas cityUnited statesNorth carolinaNew havenOverland parkKyle mccordLincoln kienholzMarcos davilaDylan raiolaJadyn davisMatt rhuleDilin jonesCarter nelsonS koi perichBraelon allenTommie frazier

Novartis settles one of two MS drug patent disputes

Action against generics group Mylan continues after terms agreed with rival generics player Accord Healthcare in patent infringement case

Justice denis mcdonaldPaul coughlanFingolimod mylanHigh courtMylan healthcare ltdMylan healthcare ireland ltdAccord healthcare ltdNovartis ireland ltdSpain based accord healthcareFingolimod accordMcdermott laboratoriesGerard laboratoriesMylan dublinAccord healthcare

Cipla, Aurobindo, Viatris in licensing pact with MPP to produce generic versions of ViiV Healthcare HIV drug

Aurobindo and Viatris will manufacture in India; Cipla will manufacture in India and has plans to manufacture in South Africa as well.

South africaPhilippe dunetonMitchell warrenDeborah waterhouseCharles goreDrug administrationGlobal fundWorld health organizationCoalition to accelerate access longSaharan africaViiv healthcareSaharan africanExecutive directorAccelerate accessMedicines patent pool

Biocon says USFDA issued CRL for Bevacizumab license application

The biologics license application was filed for Bevacizumab by Biocon’s partner Viatris

Viatris mylanBiocon biologicsBiocon ltdBiologics license applicationPreventive actionBiocon biologic

vimarsana © 2020. All Rights Reserved.